|
|
|
Volumn 53, Issue 1374, 2011, Pages 77-78
|
|
Vemurafenib (Zelboraf) for metastatic melanoma.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INDOLE DERIVATIVE;
RAF PROTEIN;
SULFONAMIDE;
VEMURAFENIB;
ANIMAL;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
ENZYMOLOGY;
HUMAN;
MELANOMA;
METABOLISM;
METASTASIS;
METHODOLOGY;
REVIEW;
SQUAMOUS CELL CARCINOMA;
ANIMALS;
CARCINOMA, SQUAMOUS CELL;
CLINICAL TRIALS AS TOPIC;
HUMANS;
INDOLES;
MELANOMA;
RAF KINASES;
SULFONAMIDES;
|
|
EID: 82255170781
PISSN: None
EISSN: 15232859
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|